Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis

被引：5
|
作者：
Radstake, T. R. D. J. [1 ]
Fransen, J. [1 ]
Van Riel, P. L. C. M. [1 ]
Toonen, E.
Coenen, M. [2 ]
Donn, R. [3 ]
机构：
[1] Radboud Univ Nijmegen Med Ctr, Dept Rheumatol & Expt Rheumatol & Adv Therapeut, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands
[3] Univ Manchester, Ctr Mol Med, Manchester M13 9PL, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2008年 / 67卷 / 01期
关键词：
D O I：
10.1136/ard.2007.079111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [41] Functional characterization of the turkey macrophage migration inhibitory factor
    Park, Myeongseon
    Kim, Sungwon
    Fetterer, Raymond H.
    Dalloul, Rami A.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2016, 61 : 198 - 207
  • [42] Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
    Eriksson, Jonas K.
    Jacobsson, Lennart
    Bengtsson, Karin
    Askling, Johan
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (02) : 364 - 370
  • [43] Cardiovascular Disease Risk Factor Modification Decreases HS-CRP and Macrophage Migration Inhibitory Factor (MIF): Influence of Gender
    Miller, Edward J.
    Mamula, Kimberly A.
    Leng, Lin
    Piecychna, Marta
    Vernalis, Marina N.
    Bucala, Richard
    Ellsworth, Darrell L.
    CIRCULATION, 2012, 126 (21)
  • [44] Distinctive Macrophage Migration Inhibitory Factor Receptor Patterns and Soluble Biomarkers in Rheumatoid Arthritis: Unveiling Key Associations with Disease Activity
    Sanchez-Zuno, Gabriela Athziri
    Bucala, Richard
    Hernandez-Bello, Jorge
    Palafox-Sanchez, Claudia Azucena
    Vizcaino-Quirarte, Alexis Missael
    Munoz-Valle, Jose Francisco
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2025, 45 (03): : 99 - 106
  • [45] Rheumatoid arthritis and risk of cardiovascular disease
    Meyer, Pieter W. A.
    Anderson, Ronald
    Ker, James A.
    Ally, Mahmood T. M.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2018, 29 (05) : 317 - 321
  • [46] MIF (macrophage migration inhibitory factor): a potential biomarker for cardiovascular disease in persons with HIV?
    Woolley, I. J.
    Ayoub, S.
    Crowe, S. M.
    Cherry, C. L.
    Visvanathan, K.
    Morand, E.
    ANTIVIRAL THERAPY, 2008, 13 (08) : A65 - A65
  • [47] PRODUCTION OF A MACROPHAGE MIGRATION INHIBITORY FACTOR IN RABBITS WITH EXPERIMENTAL ARTHRITIS
    STASTNY, P
    COOKE, TD
    ZIFF, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1973, 14 (01): : 141 - 147
  • [48] Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis
    Meazza, C
    Travaglino, P
    Pignatti, P
    Magni-Manzoni, S
    Ravelli, A
    Martini, A
    De Benedetti, F
    ARTHRITIS AND RHEUMATISM, 2002, 46 (01): : 232 - 237
  • [49] PRODUCTION OF A MACROPHAGE MIGRATION INHIBITORY FACTOR IN RABBITS WITH EXPERIMENTAL ARTHRITIS
    STASTNY, P
    ZIFF, M
    COOKE, D
    JASIN, H
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A797 - &
  • [50] PRODUCTION OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN RABBITS WITH EXPERIMENTAL ARTHRITIS
    STASTNY, P
    ZIFF, M
    COOKE, D
    ARTHRITIS AND RHEUMATISM, 1972, 15 (01): : 127 - &
12345